ES2019552A6 - Procedimiento para la preparacion de glicerofosfolipidos. - Google Patents
Procedimiento para la preparacion de glicerofosfolipidos.Info
- Publication number
- ES2019552A6 ES2019552A6 ES9001051A ES9001051A ES2019552A6 ES 2019552 A6 ES2019552 A6 ES 2019552A6 ES 9001051 A ES9001051 A ES 9001051A ES 9001051 A ES9001051 A ES 9001051A ES 2019552 A6 ES2019552 A6 ES 2019552A6
- Authority
- ES
- Spain
- Prior art keywords
- group
- hydrogen
- carbon atoms
- glycerophospholipids
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PROCEDIMIENTO PARA LA PREPARACION DE GLICEROFOSFOLIPIDOS. CONSISTE EN UN PROCEDIMIENTO PARA OBTENER NUEVOS GLICEROFOSFOLIPIDOS REPRESENTADOS POR LA FORMULA: FORMULA DONDE R REPRESENTA UN GRUPO CARBOXILO, CIANO ALCOXICARBONILO, ARILALCOXICARBONILO O ARILOXICARBONILO DE 1 A 15 ATOMOS DE CARBONO, O UN GRUPO CONRSIARSIB, DONDE RSIA Y RSIB, IGUALES O DIFERENTES ENTRE SI, SON HIDROGENO O UN GRUPO ALQUILO DE 1 A 6 ATOMOS DE CARBONO; N ES UN ENTERO ENTRE 4 Y 10; RBSI ES HIDROGENO, O UN GRUPO ALQUILO O ARALQUILO DE 1 A 22 ATOMOS DE CARBONO; RBSII ES HIDROGENO O UN GRUPO ALQUILO DE 1 A 6 ATOMOS DE CARBONO; Y RBSIII ES HIDROGENO, CARBOXILO, ALCOXICARBONILO, ARILALCOXICARBONILO O ARILOXICARBONILO DE 1 A 15 ATOMOS DE CARBONO, O UN GRUPO CONRSIARSIB COMO SE HA DEFINIDO ARRIBA. DICHOS COMPUESTOS PUEDEN SER UTILIZADOS COMO ANTITUMORALES, REGULADORES DE LA ACTIVIDAD DE LOS GLUCOCORTICOIDES, ANTIASMATICOS, ANTITROMBOTICOS, ANTIINFLAMATORIOS, ANTIALERGICOS Y EN LA PREVENCION DEL SHOCK ANAFILACTICO.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9001051A ES2019552A6 (es) | 1990-04-11 | 1990-04-11 | Procedimiento para la preparacion de glicerofosfolipidos. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9001051A ES2019552A6 (es) | 1990-04-11 | 1990-04-11 | Procedimiento para la preparacion de glicerofosfolipidos. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2019552A6 true ES2019552A6 (es) | 1991-06-16 |
Family
ID=8266854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9001051A Expired - Lifetime ES2019552A6 (es) | 1990-04-11 | 1990-04-11 | Procedimiento para la preparacion de glicerofosfolipidos. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2019552A6 (es) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2034885A1 (es) * | 1991-07-10 | 1993-04-01 | Menarini Lab | Procedimiento para la preparacion de cetoalquilglicerofosfolipidos. |
EP1341543A2 (en) * | 2000-11-24 | 2003-09-10 | Vascular Biogenics Ltd. | Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
EP1626728A2 (en) * | 2003-05-27 | 2006-02-22 | Vascular Biogenics Ltd. | Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
US8206743B2 (en) | 2000-11-17 | 2012-06-26 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
US8415318B2 (en) | 2001-10-19 | 2013-04-09 | Vascular Biogenics Ltd. | Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
US8569529B2 (en) | 2007-01-09 | 2013-10-29 | Vascular Biogenics Ltd. | High-purity phospholipids |
US8759557B2 (en) | 2004-07-09 | 2014-06-24 | Vascular Biogenics Ltd. | Process for the preparation of oxidized phospholipids |
US9006217B2 (en) | 2007-01-09 | 2015-04-14 | Vascular Biogenics Ltd. | High-purity phospholipids |
US9206206B2 (en) | 2008-11-06 | 2015-12-08 | Vascular Biogenics Ltd. | Oxidized lipid compounds and uses thereof |
US9771385B2 (en) | 2014-11-26 | 2017-09-26 | Vascular Biogenics Ltd. | Oxidized lipids |
US10022388B2 (en) | 2014-11-26 | 2018-07-17 | Vascular Biogenics Ltd. | Oxidized lipids and treatment or prevention of fibrosis |
-
1990
- 1990-04-11 ES ES9001051A patent/ES2019552A6/es not_active Expired - Lifetime
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2034885A1 (es) * | 1991-07-10 | 1993-04-01 | Menarini Lab | Procedimiento para la preparacion de cetoalquilglicerofosfolipidos. |
US8206743B2 (en) | 2000-11-17 | 2012-06-26 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
US8158611B2 (en) | 2000-11-24 | 2012-04-17 | Vascular Biogenics Ltd. | Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
EP1341543A2 (en) * | 2000-11-24 | 2003-09-10 | Vascular Biogenics Ltd. | Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
US8563534B2 (en) | 2000-11-24 | 2013-10-22 | Vascular Biogenics Ltd. | Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
EP1341543A4 (en) * | 2000-11-24 | 2009-09-02 | Vascular Biogenics Ltd | METHODS INVOLVING DEFINED OXIDE PHOSPHOLIPIDS, AND COMPOSITIONS CONTAINING THE SAME, FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS |
US7893291B2 (en) | 2000-11-24 | 2011-02-22 | Vascular Biogenics Ltd. | Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
EP2425841A1 (en) * | 2000-11-24 | 2012-03-07 | Vascular Biogenics Ltd. | Methods Employing and Compositions Containing Defined Oxidized Phospholipids for Prevention and Treatment of Atherosclerosis |
US8415318B2 (en) | 2001-10-19 | 2013-04-09 | Vascular Biogenics Ltd. | Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
US8501715B2 (en) | 2003-05-27 | 2013-08-06 | Vascular Biogenics Ltd. | Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
US7973023B2 (en) | 2003-05-27 | 2011-07-05 | Vascular Biogenics Ltd. | Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
US7902176B2 (en) | 2003-05-27 | 2011-03-08 | Vascular Biogenics Ltd. | Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
EP1626728A4 (en) * | 2003-05-27 | 2009-09-02 | Vascular Biogenics Ltd | OXIDE LIPIDS AND THEIR USE IN THE TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS |
EP1626728A2 (en) * | 2003-05-27 | 2006-02-22 | Vascular Biogenics Ltd. | Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
US8802875B2 (en) | 2004-07-09 | 2014-08-12 | Vascular Biogenics Ltd. | Process for the preparation of oxidized phospholipids |
US8759557B2 (en) | 2004-07-09 | 2014-06-24 | Vascular Biogenics Ltd. | Process for the preparation of oxidized phospholipids |
US8569529B2 (en) | 2007-01-09 | 2013-10-29 | Vascular Biogenics Ltd. | High-purity phospholipids |
US9006217B2 (en) | 2007-01-09 | 2015-04-14 | Vascular Biogenics Ltd. | High-purity phospholipids |
US9566288B2 (en) | 2007-01-09 | 2017-02-14 | Vascular Biogenics Ltd. | High-purity phospholipids |
US9206206B2 (en) | 2008-11-06 | 2015-12-08 | Vascular Biogenics Ltd. | Oxidized lipid compounds and uses thereof |
US9771385B2 (en) | 2014-11-26 | 2017-09-26 | Vascular Biogenics Ltd. | Oxidized lipids |
US10022388B2 (en) | 2014-11-26 | 2018-07-17 | Vascular Biogenics Ltd. | Oxidized lipids and treatment or prevention of fibrosis |
US10206936B2 (en) | 2014-11-26 | 2019-02-19 | Vascular Biogenics Ltd. | Oxidized lipids and treatment or prevention of fibrosis |
US10464957B2 (en) | 2014-11-26 | 2019-11-05 | Vascular Biogenics Ltd. | Oxidized lipids and methods of use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH20468A (en) | Novel pharmaceutically active di-esters of 3,5-dicarboxy-4-substituted-pyridines and pyrans | |
AU588972B2 (en) | New derivatives of 1,2,5,6-tetrahydropyridine-3- carboxaldehyde oxime, their preparation process, their use as medicaments, and the compositions containing them | |
ZA918570B (en) | Azasteroid compounds for the treatment of prostatic hypertrophy,their preparation and use | |
ES448263A1 (es) | Procedimiento para la obtencion de materiales sinteticos de poliuretano. | |
ES2019552A6 (es) | Procedimiento para la preparacion de glicerofosfolipidos. | |
ES8104321A1 (es) | Procedimiento para separar un derivado de alquil-cetohexopi-ranosida | |
ES482005A1 (es) | Procedimiento para preparar una composicion tensioactiva de-alcoxi-bis (trialcoxisiloxi)- silano. | |
ES8104391A1 (es) | Un procedimiento para preparar una composicion tensioactiva de baja formacion de espuma | |
EP0347930A3 (en) | Metallic pigment composition | |
DE3372095D1 (en) | Novel phenylpiperazine derivatives and process for producing the same | |
AU543519B2 (en) | New peptide amides and process for their manufacture | |
ES471267A1 (es) | Procedimiento para la preparacion de alquilo inferior 2-tri-(inferior) alquilsililacetileno-n-carbetoxiglicinatos y ami-no acidos derivados de ellos | |
ES8504772A1 (es) | Un procedimiento para preparar un compuesto de 7-(4-piridil)-1,8-naftiridina. | |
JPS5545690A (en) | Isomerization of 33azabicyclo*3*1*0*hexane derivative | |
ES8401957A1 (es) | Procedimiento de preparacion de derivados del acido 2-tiofen-acetico. | |
ES8608538A1 (es) | Procedimiento para la preparacion de esteres alquilicos de alfa-l-aspartil-l-fenilalanina | |
US4198500A (en) | Trans-4,5-didehydro-PGI1 amides | |
ES8505656A1 (es) | Procedimiento para la preparacion de quinolinonas-4 | |
HUT70219A (en) | 1-phenylpyrrolidone derivatives, intermediates for producing them and producing them | |
JPS55100384A (en) | Cephalosporin analog | |
GR3000378T3 (en) | Alpha-allyl substituted arylalkyltriazoles, process for their preparation and their use as fungicides | |
IE832580L (en) | Derivatives of ô-butyrolactone. | |
ES445149A1 (es) | Procedimiento de preparacion de nuevos derivados de 5-tia- zol-alcanoles. | |
ES482419A1 (es) | Un procedimiento para la preparacion de eteres del acido - clavulanico. |